ArticleJACC. Case reports2026
Congenital Long QT Syndrome Unmasked by COVID-19 Infection Presenting as Ventricular Tachycardia Storm.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCongenital long QT syndrome (LQTS) predisposes to torsades de pointes and sudden cardiac death. Although it usually manifests in childhood or early adulthood, external triggers may unmask the disease later in life. COVID-19 has been associated with cardiovascular complications, but its association with ventricular tachycardia storm precipitated by congenital LQTS is rarely reported. CASE SUMMARY: A woman in her 50s presented with recurrent syncope during acute COVID-19. Electrocardiography showed marked QTc prolongation and torsades de pointes requiring cardioversion, deep sedation, and beta-blocker therapy. She received an implantable cardioverter-defibrillator for secondary prevention and was discharged. Genetic testing later identified a pathogenic KCNQ1 variant, confirming LQT1. DISCUSSION: This case illustrates that COVID-19 can unmask latent congenital LQTS even at a late age, underscoring the importance of QT monitoring and genetic evaluation in patients with unexplained arrhythmias. TAKE-HOME MESSAGES: COVID-19 can unmask latent LQTS and trigger ventricular tachycardia storm, even in midlife. QT monitoring, genetic testing, and guideline-based therapy are essential.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.